Viewing data from:

MYCOPHENOLATE SODIUM

ANDA

MYCOPHENOLATE SODIUM | A216637 | FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MYFORTIC(TE code: AB)

API Supply Chain12 active DMFs2 inactive

12 active API suppliers hold Drug Master Files for this ingredient.

CONCORD BIOTECH LTDMYCOPHENOLATE SODIUM USP

DMF 219072008

APOTEX INCMYCOPHENOLATE SODIUM USP

DMF 228192009

BIOCON LTDMYCOPHENOLATE SODIUM

DMF 235192010

TEVA PHARMACEUTICAL INDUSTRIES LTDMYCOPHENOLATE SODIUM

DMF 241292010

FORMOSA LABORATORIES INCMYCOPHENOLATE SODIUM

DMF 243972010

EMCURE PHARMACEUTICALS LTDMYCOPHENOLATE SODIUM USP

DMF 336762019

SOLARA ACTIVE PHARMA SCIENCES LTDMYCOPHENOLATE SODIUM USP

DMF 357222021

CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDMYCOPHENOLATE SODIUM USP

DMF 358482021

CHONGQING DAXIN PHARMACEUTICAL CO LTDMYCOPHENOLATE SODIUM

DMF 378762023

WUXI FORTUNE PHARMACEUTICAL CO LTDMYCOPHENOLATE SODIUM

DMF 399632024

JOYANG LABORATORIESMYCOPHENOLATE SODIUM

DMF 408282024

RAKSHIT PHARMACEUTICALS LTDMYCOPHENOLATE SODIUM

DMF 422562025

EXCELLA GMBHInactiveMYCOPHENOLATE SODIUM

DMF 221562008

CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactiveMYCOPHENOLATE SODIUM

DMF 234352010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 180MG BASE

0 patents0 exclusivities▴

TABLET, DELAYED RELEASE;ORAL | Approved: May 29, 2024

No patent or exclusivity listings for this strength.

#002 — EQ 360MG BASE

0 patents0 exclusivities▾

TABLET, DELAYED RELEASE;ORAL | Approved: May 29, 2024